Faisal Ghiath Sukhtian
Director · Outlook Therapeutics, Inc.
- 2024
- Jul 29, 2026
- 4
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Faisal Ghiath Sukhtian files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Ghiath M. Sukhtian - $7.50M in OTLK purchases and sales in the last 12 months
- Kurt J. Hilzinger - $177K in OTLK purchases and sales in the last 12 months
- Yezan Munther Haddadin - $39K in OTLK purchases and sales in the last 12 months
- Randy H. Thurman - $2K in OTLK purchases and sales in the last 12 months
- Robert Charles Jahr - OTLK
- Lawrence A. Kenyon - OTLK
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Faisal Ghiath Sukhtian?
Faisal Ghiath Sukhtian is a corporate insider, tracked as Director of Outlook Therapeutics, Inc. (OTLK). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Faisal Ghiath Sukhtian submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Faisal Ghiath Sukhtian been buying or selling stock?
Recorded transactions: 2 open-market purchases ($150K) and 0 open-market sales across all tracked filings.
